Tamoxifen in the Management of Breast Cancer: A Case Presented in Multidisciplinary Session With Clinical Discussion and Decision-Making
Background: Selective estrogen receptor modulators (SERMs) have been shown to reduce the risk of developing estrogen-positive breast cancer. Tamoxifen, a potent SERM, has been successfully administered as adjuvant therapy for breast cancer. However, uterine pathologic changes may develop due to the...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Kaviani Breast Disease Institute
2019-02-01
|
Series: | Archives of Breast Cancer |
Subjects: | |
Online Access: | https://archbreastcancer.com/index.php/abc/article/view/234 |